"Carcinoma, Endometrioid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.
Descriptor ID |
D018269
|
MeSH Number(s) |
C04.557.470.200.025.240 C04.588.945.418.948.585.124 C13.351.500.056.630.705.331 C13.351.937.418.685.331 C13.351.937.418.875.200.124 C19.391.630.705.331
|
Concept/Terms |
Carcinoma, Endometrioid- Carcinoma, Endometrioid
- Carcinomas, Endometrioid
- Endometrioid Carcinoma
- Endometrioid Carcinomas
Adenocarcinoma, Endometrioid- Adenocarcinoma, Endometrioid
- Adenocarcinomas, Endometrioid
- Endometrioid Adenocarcinomas
- Endometrioid Adenocarcinoma
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Endometrioid".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Endometrioid [C04.557.470.200.025.240]
- Neoplasms by Site [C04.588]
- Urogenital Neoplasms [C04.588.945]
- Genital Neoplasms, Female [C04.588.945.418]
- Uterine Neoplasms [C04.588.945.418.948]
- Endometrial Neoplasms [C04.588.945.418.948.585]
- Carcinoma, Endometrioid [C04.588.945.418.948.585.124]
- Female Urogenital Diseases and Pregnancy Complications [C13]
- Female Urogenital Diseases [C13.351]
- Genital Diseases, Female [C13.351.500]
- Adnexal Diseases [C13.351.500.056]
- Ovarian Diseases [C13.351.500.056.630]
- Ovarian Neoplasms [C13.351.500.056.630.705]
- Carcinoma, Endometrioid [C13.351.500.056.630.705.331]
- Urogenital Neoplasms [C13.351.937]
- Genital Neoplasms, Female [C13.351.937.418]
- Ovarian Neoplasms [C13.351.937.418.685]
- Carcinoma, Endometrioid [C13.351.937.418.685.331]
- Uterine Neoplasms [C13.351.937.418.875]
- Endometrial Neoplasms [C13.351.937.418.875.200]
- Carcinoma, Endometrioid [C13.351.937.418.875.200.124]
- Endocrine System Diseases [C19]
- Gonadal Disorders [C19.391]
- Ovarian Diseases [C19.391.630]
- Ovarian Neoplasms [C19.391.630.705]
- Carcinoma, Endometrioid [C19.391.630.705.331]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Endometrioid".
This graph shows the total number of publications written about "Carcinoma, Endometrioid" by people in this website by year, and whether "Carcinoma, Endometrioid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2006 | 2 | 0 | 2 |
2010 | 1 | 0 | 1 |
2014 | 2 | 0 | 2 |
2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Endometrioid" by people in Profiles.
-
Jordan SE, Micaily I, Hernandez E, Ferriss JS, Miyamoto CT, Li S, Micaily B. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma. Brachytherapy. 2017 Nov - Dec; 16(6):1144-1151.
-
Desai PH, Hughes P, Tobias DH, Tchabo N, Heller PB, Dise C, Slomovitz BM. Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC). Gynecol Oncol. 2014 Nov; 135(2):196-200.
-
Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, Havrilesky L, Secord AA, Moore DT, Gehrig PA, Bae-Jump VL. The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance. Gynecol Oncol. 2014 Apr; 133(1):28-32.
-
Mhawech-Fauceglia P, Herrmann FR, Rai H, Tchabo N, Lele S, Izevbaye I, Odunsi K, Cheney RT. IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma. Am J Clin Pathol. 2010 Jun; 133(6):899-908.
-
Oliva E, Sarri? D, Brachtel EF, S?nchez-Est?vez C, Soslow RA, Moreno-Bueno G, Palacios J. High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary. J Pathol. 2006 Apr; 208(5):708-13.
-
Sanseverino F, Santopietro R, Torricelli M, D'Andrilli G, Russo G, Cevenini G, Bovicelli A, Leoncini L, Scambia G, Petraglia F, Claudio PP, Giordano A. pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor grade. Cancer Biol Ther. 2006 Jan; 5(1):84-8.
-
Elliott KS, Borowsky ME, Lee YC, Rao C, Abulafia O. Prolonged survival in recurrent endometrial carcinoma to the brain. Gynecol Oncol. 2004 Oct; 95(1):247-51.